Td Asset Management Inc Assembly Biosciences, Inc. Transaction History

Td Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $91,745 - $325,726	-18,839 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$10.27 - $21.23 $21,567 - $44,583	-2,100 Reduced 10.03%	18,839 $279,000
Q4 2019 Feb 11, 2020	BUY	$8.36 - $23.81 $175,050 - $498,557	20,939 New	20,939 $428,000
Q4 2018 Feb 01, 2019	SELL	$19.05 - $36.45 $216,827 - $414,873	-11,382 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$34.41 - $44.23 $68,200 - $87,663	1,982 Added 21.09%	11,382 $423,000
Q2 2018 Jul 31, 2018	BUY	$39.21 - $50.29 $62,736 - $80,464	1,600 Added 20.51%	9,400 $369,000
Q1 2018 May 11, 2018	BUY	$41.7 - $64.16 $325,260 - $500,448	7,800 New	7,800 $383,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.